RGC·G7487R100·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
ORDINARY SHARES
RGC (REGENCELL BIOSCIENCE HLDGS L) is held by 22 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($10.6M), Marex Group plc ($803,588), Vident Advisory, LLC ($752,423). Net institutional sentiment: Bullish.
See how RGC's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer